These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36657623)

  • 1. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
    Franke C; Boesl F; Goereci Y; Gerhard A; Schweitzer F; Schroeder M; Foverskov-Rasmussen H; Heine J; Quitschau A; Kandil FI; Schild AK; Finke C; Audebert HJ; Endres M; Warnke C; Prüss H
    Brain Behav Immun; 2023 Mar; 109():139-143. PubMed ID: 36657623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
    Franke C; Ferse C; Kreye J; Reincke SM; Sanchez-Sendin E; Rocco A; Steinbrenner M; Angermair S; Treskatsch S; Zickler D; Eckardt KU; Dersch R; Hosp J; Audebert HJ; Endres M; Ploner JC; Prüß H
    Brain Behav Immun; 2021 Mar; 93():415-419. PubMed ID: 33359380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of Novel Anti-Central Nervous System Autoantibodies in the Cerebrospinal Fluid of 119 Patients With Schizophreniform and Affective Disorders.
    Endres D; von Zedtwitz K; Matteit I; Bünger I; Foverskov-Rasmussen H; Runge K; Feige B; Schlump A; Maier S; Nickel K; Berger B; Schiele MA; Cunningham JL; Domschke K; Prüss H; Tebartz van Elst L
    Biol Psychiatry; 2022 Aug; 92(4):261-274. PubMed ID: 35606187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
    Finke C; Bartels F; Lütt A; Prüss H; Harms L
    J Neurol; 2017 Sep; 264(9):1968-1977. PubMed ID: 28785798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples.
    Pankratz B; von Zedtwitz K; Runge K; Denzel D; Nickel K; Schlump A; Pitsch K; Maier S; Dersch R; Voderholzer U; Domschke K; Tebartz van Elst L; Schiele MA; Prüss H; Endres D
    World J Biol Psychiatry; 2023 Apr; 24(4):292-302. PubMed ID: 35904379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer.
    Bartels F; Wandrey MM; Aigner A; Strönisch T; Farmer K; Rentzsch K; Tessmer A; Grohé C; Finke C
    JAMA Oncol; 2021 Sep; 7(9):1302-1310. PubMed ID: 34196651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of anti-neuronal antibodies in children with neurological disorders beyond encephalitis.
    Nikolaus M; Meisel C; Kreye J; Prüss H; Reindl M; Kaindl AM; Schuelke M; Knierim E
    Eur J Paediatr Neurol; 2020 Sep; 28():159-166. PubMed ID: 32807683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort.
    Hansen N; Malchow B; Zerr I; Stöcker W; Wiltfang J; Timäus C
    J Neural Transm (Vienna); 2021 Mar; 128(3):357-369. PubMed ID: 33677623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients.
    Liu T; Chen B; Yang H; Huang J; Liu S; Yang X; Huang L; Yao H; Qiu W; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Feb; 28():177-183. PubMed ID: 30611927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis.
    Endres D; Meixensberger S; Dersch R; Feige B; Stich O; Venhoff N; Matysik M; Maier SJ; Michel M; Runge K; Nickel K; Urbach H; Domschke K; Prüss H; Tebartz van Elst L
    Transl Psychiatry; 2020 Aug; 10(1):279. PubMed ID: 32782247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.
    Reinhold D; Farztdinov V; Yan Y; Meisel C; Sadlowski H; Kühn J; Perschel FH; Endres M; Düzel E; Vielhaber S; Guttek K; Goihl A; Venø M; Teegen B; Stöcker W; Stubbemann P; Kurth F; Sander LE; Ralser M; Otto C; Streit S; Jarius S; Ruprecht K; Radbruch H; Kjems J; Mülleder M; Heppner F; Körtvelyessy P
    J Neuroinflammation; 2023 Feb; 20(1):30. PubMed ID: 36759861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of cerebrospinal fluid antibodies associated with autoimmune encephalitis of humans in dogs with neurologic disease.
    Stafford EG; Kortum A; Castel A; Green L; Lau J; Early PJ; Muñana KR; Mariani CL; Yoder JA; Olby NJ
    J Vet Intern Med; 2019 Sep; 33(5):2175-2182. PubMed ID: 31495976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients.
    Lavi Y; Vojdani A; Halpert G; Sharif K; Ostrinski Y; Zyskind I; Lattin MT; Zimmerman J; Silverberg JI; Rosenberg AZ; Shoenfeld Y; Amital H
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
    J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
    Di Domenico F; Pupo G; Giraldo E; Lloret A; Badia MC; Schinina ME; Giorgi A; Butterfield DA; Vina J; Perluigi M
    Curr Alzheimer Res; 2016; 13(2):112-22. PubMed ID: 26679861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
    Schild AK; Goereci Y; Scharfenberg D; Klein K; Lülling J; Meiberth D; Schweitzer F; Stürmer S; Zeyen P; Sahin D; Fink GR; Jessen F; Franke C; Onur OA; Kessler J; Warnke C; Maier F
    J Neurol; 2023 Mar; 270(3):1215-1223. PubMed ID: 36422669
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.